NCT01296204View on ClinicalTrials.gov

Radioimmunotherapy (RIT) in MULTIPLE MYELOMA Using the Antibody B-B4 Radiolabelled With IODE 131

PHASE1CompletedINTERVENTIONAL

Enrollment

33

Participants

Timeline

Start Date

Not specified

Conditions

Multiple Myeloma

Interventions

DRUG

BB4 antibody-Iodine 131

Injection of an antibody after labelling with Iodine 131

Trial Locations (2)

44805

Centre René Gauducheau, Nantes

Unknown

Moreau, Nantes

All Listed Sponsors

lead

Centre René Gauducheau

OTHER